Primobolan carries absolutely no risk of estrogen-related side effects at any dosage, and its androgen strength rating is extremely low, making the possibility of androgen-related side effects much lower than most anabolic steroids.
Thanks to these characteristics, Primobolan is considered one of the “mildest” anabolic steroids and is often compared to Anavar.
Both drugs have a low risk of side effects, are used medically for treating women and children, and are recognized for their safety and minimal adverse effects.
However, Primobolan has weaker anabolic strength compared to most anabolic steroids, and even when compared to Anavar, differences exist not only in side effects but also in potency.
Consequently, the similarity between the two drugs applies only in a limited context regarding side effects.
Estrogen-Related Side Effects
Primobolan is a DHT-derived anabolic steroid that does not interact with the aromatase enzyme, meaning it does not convert into estrogen at any dosage.
As a result, no estrogenic side effects occur with Primobolan use, and estrogen-related issues such as water retention, increased blood pressure (due to water retention), and gynecomastia do not develop.
This characteristic makes Primobolan a safe option even for users who are sensitive to estrogen-related side effects. [1]
Androgen-Related Side Effects
Primobolan has a much lower androgen strength compared to testosterone, but individuals sensitive to androgen-related side effects may still experience them.
All anabolic steroids exhibit androgen effects to some degree, and Primobolan belongs to the category with relatively low androgen activity.
However, this does not mean the possibility of androgen-related side effects can be completely ruled out with Primobolan use.
Common androgen-related side effects include oily skin due to increased sebum production, increased acne breakouts, growth of body and facial hair, and an increased risk of triggering Male Pattern Baldness (MPB) in genetically predisposed individuals.
Additionally, female users may experience virilization symptoms (deepening of the voice, growth of body and facial hair, clitoral enlargement, menstrual irregularities).
However, for female users, maintaining an appropriate dosage and designing cycles to be short and moderate can minimize these symptoms.
One of Primobolan’s unique advantages is that it does not interact with the 5-alpha reductase enzyme, meaning it is not converted into a more potent androgen.
Therefore, Primobolan’s androgen strength remains consistent throughout the cycle, providing stable characteristics that lower the likelihood of unexpected side effects.
HPTA and Endogenous Testosterone Production Side Effects
All anabolic steroids, including Primobolan, induce a negative feedback loop on the Hypothalamic-Pituitary-Testicular Axis (HPTA), suppressing or halting endogenous testosterone production.
Primobolan is often described as having a “mild suppressive effect,” but this is incorrect information.
In reality, at bodybuilding doses, Primobolan tends to strongly suppress endogenous testosterone production.
Research indicates that administering just 30-45mg of Primobolan per day suppressed subjects’ testosterone production by 1565%.
Given that bodybuilding doses typically exceed 100mg, Primobolan exhibits significant suppressive effects.
Consequently, without proper PCT (Post-Cycle Therapy) after cycle completion, the recovery of endogenous testosterone can be delayed, or long-term damage to the HPTA may occur, making a systematic PCT essential to prevent this. [2]
Hepatotoxicity Side Effects
Injectable Primobolan (Methenolone Enanthate) and oral Primobolan (Methenolone Acetate) do not have C17-alpha alkylation, so they cause almost no hepatotoxic side effects.
Oral Primobolan shows no changes in liver enzyme levels and is resistant to hepatic metabolism.
Despite high-dose use, the actual risk of hepatotoxicity is relatively low; however, as the dosage increases, the impact on the liver can become greater, so this should not be completely ignored.
Injectable Primobolan bypasses the first-pass pathway through the liver, so hepatotoxicity issues do not occur. [3][4]
Cardiovascular Side Effects
All anabolic steroids, including Primobolan, can negatively impact the cardiovascular system, with primary side effects including a decrease in HDL (good cholesterol) and an increase in LDL (bad cholesterol).
This increases the risk of atherosclerosis, and these changes worsen further, especially with high-dose use.
Furthermore, oral anabolic steroids have a more negative impact on cholesterol compared to injectable forms, which is related to how cholesterol is processed in the liver.
Therefore, when using anabolic steroids, a clean diet and intake of healthy cholesterol-promoting foods like omega-3 fatty acids and fish oil are essential.
Primobolan Reference Papers
- Proc. Intern. Congr. Hormonal Steroids, Milan, 1962. Excerpta Med. Intern. Congr. Ser No. 51, p. 209. Excerpt. Med. Found., Amsterdam, 1962.
- Comparative studies on the effects of methenolone acetate and mesterolone on the pituitary and male gonads. Trenkner R, Senge T, Hienz H et al. Arzneimittelforschung. 1970 20(4):545-7.
- Failure of non-17-alkylated anabolic steroids to produce abnormal liver function tests. J Clin Endocrinol Metab. 1964 Dec;24:1334-6.
- Fatal outcome in a patient with severe aplastic anemia following methenolone acetate therapy. Ann Hematol. 1993 Jul;67(1):41-3. Tsukamoto N, Uchiyama T, Takeuchi T, Sato S, Naruse T, Nakazato Y.
